Berlin · Pre-Seed–Series A · 8 people tracked
Also known as Amino Collective 1 Gmb H & Co. KG
Find your way into Amino Collective
Sign up to see every warm intro you have to Amino Collective
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amino Collective team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Amino Collective invests in founders who dare to venture into the unknown, valuing originality and boldness over conventional approaches. The firm's ethos centers on backing 'free and radical' entrepreneurs who pursue differentiated paths rather than incremental ideas.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directoriesWhat they invest in
from 15 of 45 portfolio companiesAI & Machine Learning ×13Healthtech ×8Biotech ×6SaaS ×5Deep Tech ×4Digital Health ×3Enterprise Software ×3Data & Infrastructure ×2
HQs:United Kingdom×5United States×4Germany×1
Investments · 45 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 32024 · 22023 · 22022 · 22021 · 12019 · 112 dated
Anima is a healthcare platform that combines online consultation with productivity tools, featuring EHR integration, advanced analytics, and AI-powered document processing to streamline primary care workflows and improve patient outcomes.
AI & Machine LearningDigital HealthHealthtechSaaSLondon, GB
Shun Pang(Founder)inRachel Mumford(Founder)inInga Deakin(Director)Shun Pang Rachel Mumford(Founder)Jayanth Kottapalli(Engineering)inRuoni Wang(Engineering)in
Co-investorsHetz VenturesHummingbird VenturesMolten VenturesY CombinatorHarvard Management CompanyINcapital Ventures+1 more
Anima is a gaming and interactive technology company that uses artificial intelligence to create virtual characters and worlds.
AI & Machine LearningConsumerGaming
Co-investorsCoinbase VenturesLD CapitalNarcissus VenturesYBB FoundationHummingbird VenturesMolten Ventures+1 more
ExpressionEdits builds a computational platform, the Genetic Syntax Engine, that uses AI and intron-based transgene design to improve protein expression for therapeutic applications.
AI & Machine LearningBiotechDeep Tech
Dr. Liliana Antunes(Group Leader, RNA Technologies; Co-founder)Kärt Tomberg(CEO; Co-founder; Director)inProf. Allan Bradley(Co-founder; Non-Executive Director)
Co-investorsBlueYard CapitalHAWKTAILOctopus VenturesAcequia Capital (AceCap)redalpineWilbe Capital
Frontier Computing grows lab-cultured biological neural networks at large scale to serve as a training substrate for machine learning, colocating memory and compute to support training of large-parameter models.
Advanced ManufacturingAI & Machine LearningHardwareLondon, GB
Michael Domarkas(CEO)in
Co-investorsLocalGlobePioneerWSSY CombinatorAcephale VenturesAndreessen Horowitz+18 more
Fundrbird provides software solutions for GP (general partner) firms to build and scale their fund management operations.
Enterprise SoftwareFintechSaaS
Co-investorsCuriosity VCEndeit CapitalHealthy.CapitalHolland CapitalMundi VenturesPride Capital Partners+5 more
Junction provides a unified API platform that connects healthcare providers, wellness companies, and EHR systems to a nationwide network of labs and 300+ medical devices.
Data & InfrastructureHealthtechSaaSWellness & FitnessLondon, GB
Maitham Dib(Founder)inFemi AwomosuNaomi Yudanin(Head of Data \u0026 AI)Rui Peres(Head of Engineering)Simba Deu(Chief of Staff)Beth Toms(Head of Talent)
Co-investors20VCAdventure FundAlliance DAO (ex DeFi Alliance)Point NineWormhole CapitalY Combinator+5 more
Junction AI is a Managed Intelligence Partner that builds, deploys, and manages production AI systems micro-tuned on a company's proprietary data, with built-in compliance rules, audit trails, and human-in-the-loop review.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsBlue StartupsHawke VenturesCreandumInflect HealthOmnivorePoint Nine+1 more
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)Burak YILMAZ(Founder)in
Co-investorsAsymmetry VenturesCivilization Ventures Management, LlcFoundersX VenturesHOF CapitalHummingbird VenturesSAV (Scale Asia Ventures)+13 more
Lir develops AI-driven viral vector engineering for gene therapy, using machine learning to optimize AAV (adeno-associated virus) vectors for improved dose efficiency, tissue targeting, and immune evasion.
AI & Machine LearningBiotechDeep Tech
Killian Hanlon(Co-founder)inHugh O'Brien(Co-founder)in
Co-investorsFly Ventures
Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases.
AI & Machine LearningBiotechDigital HealthHealthtechBerlin, DE
David Gorgan(Founder)inRocio Acuna Hidalgo(Founder)in
Co-investors42CAPAcequia Capital (AceCap)Entrepreneur FirstFaberFrontline Ventures
Rematiq builds an AI-driven platform for product and regulatory compliance in life sciences, connecting requirements, regulations, evidence and submissions in one system and automating traceability, compliance checks and document generation.
AI & Machine LearningHealthtechSaaS
David Boutellier-Saxer(Founder)in
Co-investorsProject A Ventures
Scale provides high-quality training data, model evaluations, and full-stack AI systems for enterprises and governments to build and deploy AI applications.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US
Alexandr Wang(CEO)inLucy Guo(Founder)inFrancis deSouza(CEO)inTim Dingman(Strategic Product Manager)inCharles Lambert(Web Developer)Jesse Tinsley
Co-investors1435 CapitalAccelAdit Ventures Management, LlcAIspace VenturesAlpana VenturesAlpha Square Group+104 more
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in
BoardVishal Gulati(Director)Joel Schoppig(Director)
Co-investorsCivilization Ventures Management, LlcKAYARecode VenturesTraun VenturesY CombinatorZAKA VC+11 more
Serna builds a platform to unlock the transcriptome as a drug target for drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechOntario, US
Rabia Khan(Founder)inAaron Lazarus(Chief of Staff)inPaul Bradley-Law(Head of People Ops)
Co-investorsBackedHummingbird VenturesLifeforce CapitalY CombinatorAME Cloud VenturesAxial VC+3 more
Tandem Health builds regulated clinical AI for clinicians and health systems, including an AI scribe that generates clinical documents and diagnosis/procedure codes (ICD-10, SNOMED), a coding assistant, and clinical decision support certified as EU MDR Class IIa medical devices.
AI & Machine LearningDigital HealthHealthtech
Lukas Saari(Founder)inOliver Astrand(Founder)Oscar Boldt-Christmas(Founder)
Co-investorsGROOVE CAPITALIdeashipInception FundKinnevikNorthzoneEQT+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AI-Native Drug Discovery CROCalibreCancer Drug Discovery PlatformClinical Trial AI PlatformClinical Trials PlatformClinician CopilotDrug Discovery Prediction PlatformEnterprise AI Context GraphExscientiaGene Therapy PlatformGenomic Data PlatformHealth Data Integration PlatformLindusLiquid Biopsy PlatformMedicinal Plant Drug DiscoverymRNA Cancer TreatmentNanopore Proteomics PlatformPrecision Fermentation Drug DiscoveryProtein Design PlatformRNA Therapeutics ManufacturingScale MedicineScience IP-NFT MarketplaceScientific R&D AutomationSubstrate BioSynthetic DNA Gene ExpressionTelemedicine PlatformTextile Waste RecyclingTranscriptome Discovery PlatformVirtual Patient ModelingWomen's Health Digital Therapeutics
Portfolio news
latest coverage across their companiesTandem Health · techfundingnews.com · Sep 14, 2026
Frontier Computing · en.wowtale.net · Sep 1, 2026
Frequently asked questions
- How many investments has Amino Collective made?
- Amino Collective has 45 tracked investments, including 4 dated in the last 24 months.
- What stage does Amino Collective invest at?
- Amino Collective invests at the Pre-Seed, Seed, Series A stages.
- What is Amino Collective's typical check size?
- Amino Collective typically writes checks of $216K – $1.6M.
- What sectors does Amino Collective focus on?
- Amino Collective focuses on Biotech, Digital Health, Healthtech.
- Where is Amino Collective located?
- Amino Collective is headquartered in Berlin, DE.
- Who does Amino Collective co-invest with?
- Amino Collective most often shares deals with Endeit Capital, Fly Ventures, Mundi Ventures, among 13 tracked co-investors.
Images
Co-investors · 29
Creandum is a venture capital firm that invests in technology companies, backing them at early stages before their potential becomes widely obvious.
Hummingbird Ventures is a global venture capital firm that backs outlier founders across all stages, from inception to IPO, without limiting itself to specific verticals or geographies.
Acequia Capital is an early-stage investment platform supporting technical founders and product teams building global technology businesses.
Blueyard is a small equal partnership with offices in the US and Europe, investing in early-stage companies.
Founders Fund is a venture capital firm that backs technology companies building transformative products.
Pioneer Fund is an investment fund backed by 540+ Y Combinator alumni that invests in and supports top startups coming out of Y Combinator.
Entrepreneur First (EF) is a talent investor that helps individuals build and launch startups, providing support such as US visa guidance, office space, fundraising preparation, and investor introductions culminating in a San Francisco Demo Day.
LocalGlobe is part of a multi-generational Phoenix Court platform that backs companies from pre-seed through public markets, founded by the Klein family who are considered founders of European seed investing with multi-decade relationships across the European tech ecosystem. The fund operates from a physical founder village at Phoenix Court in London and focuses on backing unconventional entrepreneurs in specific geographic neighbourhoods, having been among the earliest institutional backers of European outliers like Wise, Zoopla, and Citymapper.
Fifty Years (50Y) is a pre-seed and seed-focused venture capital firm that backs founders using technology to solve major global problems, and also helps start companies.
Molten Ventures invests in European technology companies across sectors including fintech, AI, climate and quantum, with a portfolio spanning over 100 companies.
42CAP is a European seed-stage venture capital firm founded by entrepreneurs who previously built two of Europe's largest software companies. It invests in tech- and data-driven B2B software startups with global ambitions.
▶17 more co-investors
HeadlineAntlerCherry VenturesLakestarHeartcore CapitalFreigeist CapitalDawn CapitalPresight CapitalTMVBand of AngelsAlbionVCAvalanche VCAir Street CapitalTalis CapitalCerulean VenturesCambridge Angels groupPalo Santo VC
Firms observed investing alongside Amino Collective, from public investor directories. Shared companies are the overlap with Amino Collective's recorded portfolio.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.

































.png)













































.jpeg)
